AXIOS December 6, 2021
Bob Herman

American businesses spend hundreds of billions of dollars a year on prescription drugs, and the bills keep getting bigger. But some of the companies promising to help rein in those costs prevent employers from looking under the hood.

Why it matters: Documents provided to Axios reveal a new layer of secrecy within the maze of American drug pricing — one in which firms that manage drug coverage for hundreds of employers, representing millions of workers, obscure the details of their work and make it difficult to figure out whether they’re actually providing a good deal.

The big picture: Americans spent $370 billion on retail prescription drugs in 2019, and employers shouldered about $166 billion of that, according to federal data.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Pricing / Spending, Provider
Reproductive health company Stork Club announces expanded offerings in 100 countries
Employers must provide accommodations for abortions, contraception under new rule
Midlife mortality higher in US than other high-income countries
Why CFOs struggle to reach the CEO seat
Health savings accounts have mixed effects on healthcare spending, use

Share This Article